Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

Meyers PA, Gorlick R, Heller G, Casper E, Lane J, Huvos AG, Healey JH.

J Clin Oncol. 1998 Jul;16(7):2452-8.

PMID:
9667263
2.

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V, Rosen G.

J Clin Oncol. 1992 Jan;10(1):5-15.

PMID:
1370176
3.

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.

Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES, Kisker CT, Miser JS.

J Clin Oncol. 1997 Jan;15(1):76-84.

PMID:
8996127
5.

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfürst C, Berger J, Ritter J, Jürgens H, Gerein V, et al.

J Clin Oncol. 1988 Feb;6(2):329-37.

PMID:
2448428
6.

Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering.

Meyers PA, Heller G, Vlamis V.

Cancer Treat Res. 1993;62:309-22. Review. No abstract available.

PMID:
7682091
7.

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, Hogendoorn PC, Memon MA, Weeden S, Uscinska BM, van Glabbeke M, Kirkpatrick A, Hauben EI, Craft AW, Taminiau AH; MRC BO06 and EORTC 80931 collaborators; European Osteosarcoma Intergroup.

J Natl Cancer Inst. 2007 Jan 17;99(2):112-28.

PMID:
17227995
8.

Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.

Ferrari S, Ruggieri P, Cefalo G, Tamburini A, Capanna R, Fagioli F, Comandone A, Bertulli R, Bisogno G, Palmerini E, Alberghini M, Parafioriti A, Linari A, Picci P, Bacci G.

J Clin Oncol. 2012 Jun 10;30(17):2112-8. doi: 10.1200/JCO.2011.38.4420. Epub 2012 May 7.

PMID:
22564997
9.

Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.

Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C.

Cancer. 1982 Mar 15;49(6):1221-30.

10.

Risk-Based Therapy for Localized Osteosarcoma.

Venkatramani R, Murray J, Helman L, Meyer W, Hicks MJ, Krance R, Lau C, Jo E, Chintagumpala M.

Pediatr Blood Cancer. 2016 Mar;63(3):412-7. doi: 10.1002/pbc.25808. Epub 2015 Oct 26.

PMID:
26501936
11.

Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.

Rosen G, Huvos AG, Marcove R, Nirenberg A.

Clin Orthop Relat Res. 1986 Jun;(207):164-73.

PMID:
2424660
12.

Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response.

Ferrari S, Mercuri M, Picci P, Bertoni F, Brach del Prever A, Tienghi A, Mancini A, Longhi A, Rimondini S, Donati D, Manfrini M, Ruggieri P, Biagini R, Bacci G.

Tumori. 1999 Nov-Dec;85(6):458-64.

PMID:
10774566
13.

Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.

Cho Y, Jung GH, Chung SH, Kim JY, Choi Y, Kim JD.

Clin Orthop Surg. 2011 Mar;3(1):48-54. doi: 10.4055/cios.2011.3.1.48. Epub 2011 Feb 15.

14.

Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

Goorin AM, Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, Helman LJ, Grier HE, Link MP; Pediatric Oncology Group.

J Clin Oncol. 2003 Apr 15;21(8):1574-80.

PMID:
12697883
15.

Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.

Rha SY, Chung HC, Gong SJ, Shim KY, Ahn JB, Yang WI, Shin KH, Yoo NC, Kim JH, Roh JK, Lee CI, Kim BS.

Oncol Rep. 1999 May-Jun;6(3):631-7.

PMID:
10203605
16.

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators.

J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1.

17.

Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.

Ekert H, Tiedemann K.

Cancer Treat Res. 1993;62:355-9. No abstract available.

PMID:
7682094
18.

Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors.

Rosen G, Caparros B, Groshen S, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Huvos AG.

Cancer Invest. 1984;2(3):181-92.

PMID:
6203625
19.

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.

Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A, Brach del Prever A, Gherlinzoni F, Mercuri M, Monti C.

Cancer. 1993 Dec 1;72(11):3227-38.

20.

Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.

Bacci G, Briccoli A, Ferrari S, Saeter G, Donati D, Longhi A, Manfrini M, Bertoni F, Rimondini S, Monti C, Forni C.

Oncol Rep. 2000 Mar-Apr;7(2):339-46.

PMID:
10671683

Supplemental Content

Support Center